Your browser version may not work well with NCBI's Web applications. More information here...
Related Articles, Links
Click here to read
Comment on:
Telmisartan, ramipril, or both in patients at high risk of vascular events.

Messerli FH, Bangalore S, Ram VS.

Publication Types:
PMID: 18655247 [PubMed - indexed for MEDLINE]